Quest Bets on the Future of Diagnostics in Neurology with Purchase from Thermo Fisher

We think Quest Diagnostics' DGX planned acquisition of Thermo Fisher's TMO Athena diagnostics unit makes strategic sense; we're leaving our fair value estimate intact because we already had baked in a level of ongoing acquisitions. However, the...